Ownership history in CITADEL ADVISORS LLC · 20 quarters on record
This page tracks every 13F SEC filing in which CITADEL ADVISORS LLC reported a position in WEREWOLF THERAPEUTICS INC (HOWL). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 154,534 | +154,234 | +51411.3% | 0.00% | $304K | $1.97 |
| 2025 Q1 | REDUCED | 300 | -13,300 | -97.8% | 0.00% | $292 | $0.97 |
| 2025 Q1 | REDUCED | 13,600 | -400 | -2.9% | 0.00% | $13K | $0.97 |
| 2024 Q4 | ADDED | 14,000 | +12,000 | +600.0% | 0.00% | $21K | $1.48 |
| 2024 Q4 | ADDED | 2,000 | +1,500 | +300.0% | 0.00% | $3K | $1.48 |
| 2024 Q3 | REDUCED | 500 | -11,007 | -95.7% | 0.00% | $1K | $2.12 |
| 2024 Q3 | ADDED | 11,507 | +10,807 | +1543.9% | 0.00% | $24K | $2.12 |
| 2024 Q3 | REDUCED | 700 | -900 | -56.2% | 0.00% | $1K | $2.12 |
| 2024 Q2 | REDUCED | 1,600 | -62,354 | -97.5% | 0.00% | $4K | $2.44 |
| 2024 Q2 | ADDED | 63,954 | +62,654 | +4819.5% | 0.00% | $156K | $2.44 |
As of 2025 Q4 — sorted by position size